Improving Artificial Intelligence-derived Algorithms for Estimating Length and Weight in NEonateS and infanTs up to 6 Months of Age (NEST)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-6
SponsorDanone Asia Pacific Holdings Pte, Ltd.

About this trial

The NEST study is a prospective, observational research study designed to collect clinical measurements and image data to develop and evaluate artificial intelligence (AI)-derived algorithms for estimating anthropometric parameters in neonates and young infants. The study focuses on infants from birth up to 6 months of age and aims to assess the accuracy of AI-based estimations of length, weight, and head circumference using photographs and/or video recordings captured during routine clinical care. These AI-derived measurements will be compared against standard clinical measurements obtained by trained healthcare professionals in neonatal and infant care settings.

Eligibility criteria

Qualifiers

Infants up from birth up to 6 months of postnatal age (including neonates) who have been admitted to the NICU or SCN at the time of screening

Parent(s) should be able to comprehend the content of the study and be willing for their child to undergo video and photo recording, and to allow access to their blood sampling results (haemoglobin) taken as part of standard clinical practice

Written consent from parents and/or legally acceptable representative

Disqualifiers

Infants who were born with gestational age of less than 28 weeks of gestational age

Infants who are intubated (i.e., endotracheal, nasotracheal intubation) at the time of screening

The investigator considers for any reason that the participant would not be suitable for the study

The participant has an existing medical condition that would prevent standardised measurement of length and/or head circumference e.g. structural abnormality of the lower limbs, orthopaedic conditions, hydrocephalus

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

60 Participants
are grouped into 1 trial group

Sponsors and collaborators

Danone Asia Pacific Holdings Pte, Ltd.

Lead sponsor

KK Women's and Children's Hospital

Collaborator